Altamira Therapeutics Ltd.
CYTOF
←Back to Recent Filings

Filing DATE FP FY End Date URL VIEW
6-K 8/29/2025 Q2 2025 6/30/2025 SEC view
20-F 5/1/2025 Q4 2024 12/31/2024 SEC view
6-K 9/24/2024 Q2 2024 6/30/2024 SEC view
20-F/A 7/1/2024 Q4 2023 12/31/2023 SEC view
20-F/A 4/22/2024 Q4 2023 12/31/2023 SEC view
20-F 4/10/2024 Q4 2023 12/31/2023 SEC view
20-F 4/10/2024 Q4 2023 12/31/2023 SEC view
6-K 9/12/2023 Q2 2023 6/30/2023 SEC view
6-K/A 8/21/2023 Q2 2022 6/30/2022 SEC view
20-F 5/16/2023 Q4 2022 12/31/2022 SEC view
6-K 11/30/2022 Q2 2022 6/30/2022 SEC view
20-F 4/12/2022 Q4 2021 12/31/2021 SEC view
6-K 9/8/2021 Q2 2021 6/30/2021 SEC view
20-F 3/31/2021 Q4 2020 12/31/2020 SEC view
6-K/A 9/17/2020 Q2 2020 6/30/2020 SEC view
20-F 4/16/2020 Q4 2019 12/31/2019 SEC view
WIREPR 8/15/2019 Q2 2019 6/30/2019 WIRE view data
6-K 8/15/2019 Q2 2019 6/30/2019 SEC view
20-F 3/14/2019 Q4 2018 12/31/2018 SEC view
F-4/A 2/13/2019 Q3 2018 9/30/2018 SEC view
F-1/A 2/13/2019 Q3 2018 9/30/2018 SEC view
20-F 3/22/2018 Q4 2017 12/31/2017 SEC view